Pankaj Dalal

Pankaj Dalal has extensive work experience in the field of biotechnology and pharmaceuticals. Pankaj is currently working as a Sr Director-CMC and Process Development at Seraxis. Prior to this, they worked at Revance Therapeutics, Inc. as a Principal Scientist, where they led late-stage process development for a drug substance adhering to safety standards and implemented risk-based and QbD approaches for microbial platform development. Before that, they held the role of Senior Scientist at Adello Biologics, LLC and Associate Director at AstraZeneca. Pankaj also worked as a Sr. Scientist at Boehringer Ingelheim and Staff Scientist at bioMérieux. Pankaj Dalal started their career at Cadila Pharmaceuticals Ltd as an Assistant General Manager in biotechnology, where they cloned and expressed Hepatitis B surface antigen in yeast. Pankaj has experience in various aspects of process development, including optimization, purification, downstream process development, and scale-down models.

Pankaj Dalal pursued their education in the field of Microbiology, starting with their M.Sc degree at Gujarat University from 1979 to 1981. Pankaj then continued their academic journey at Paris-Sud University (Paris XI) where they completed their Ph.D in Microbiology from 1985 to 1989.